Colorectal cancer is one of the most common cancers in Norway, which also has one of the highest incidence rates in the world ...

In the phase 2 MASTERPLAN trial, adding SBRT to chemotherapy lowered the rate of cancer returning near the pancreas from 52.0% to 20.2% at one year.

The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach ...

Personalized mRNA vaccines against melanoma—the deadliest form of skin cancer—reduced the risk of death or recurrence by 42 ...

Despite advances in early-stage lung cancer treatment, a significant number of patients experience disease recurrence after ...

New findings suggest that a blood test can detect circulating tumor DNA (ctDNA), potentially identifying signs of lung cancer ...

Singapore’s RACES study finds higher-risk node-negative early breast cancer patients had similar seven-year recurrence or death rates to node-positive patients.

Sacituzumab tirumotecan improved survival 32% compared with chemotherapy for patients with advanced or recurrent endometrial cancer, according to randomized phase 3 trial data presented at European ...

Beginning survivorship care for head and neck cancer patients earlier is linked to better survival and lower recurrence, ...

Although completing treatment is a significant milestone, the risk of recurrence can persist, sometimes for years.

A first-of-its-kind vaccine against cancer may be on the horizon.

Cancer is a chronic condition that can reoccur after effective treatment. Fear of cancer recurrence (FCR) is common and can negatively affect a person’s daily life. Although fear of the unknown is a ...